Obestatin stimulates the secretion of pancreatic juice enzymes through a vagal pathway in anaesthetized rats - preliminary results.
Obestatin is a 23 amino acid peptide derived from the preproghrelin precursor, and originally purified from the rat stomach mucosa. It was shown that obestatin may counteract the effects of its sister peptide, ghrelin, on food intake and gastrointestinal motility but the other roles in controlling the gastrointestinal function remain unknown. The aim of the present study was to determine the influence of exogenous obestatin on the secretion of pancreatic juice. In anesthetized male Wistar rats the external jugular vein was catheterized, and the common biliary-pancreatic duct was cannulated with polyethylene tubing for collection of pancreatic-biliary juice (P-BJ). Obestatin boluses (30, 100 and 300 nmol/kg b. wt.) were injected intravenously or intraduodenally every 30 min. Obestatin was also administered in vagotomized (subdiaphragmatic vagotomy) rats. In the examined rats, obestatin intravenous and intraduodenal boluses did not affect the P-BJ volume. On the other hand, obestatin boluses increased the protein output and trypsin activity. Vagotomy abolished the effects of exogenous obestatin administration. In conclusion, the present study demonstrates for the first time that exogenous obestatin may stimulate the secretion of pancreatic juice enzymes. The effect is dose-dependent and requires intact vagal supply.